Pronova Biopharma Norge AS
Omega-3-based pharmaceuticals
Export Market
Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
Additional Information
Finance
Total revenue: 1.156.181
Operating profit: 169.641
Operating profit before tax: 171.079
Total assets: 886.163
Total equity: 130.391
Currency: NOK (all numbers in thousands)
Management
Board Chairman:
Harald Pflanzl
Board Members:
Alexandra Bjerch-Andresen
Hilde Nyheim
Mark Walter Meier
Thomas Reiersen
Tor-Andre Andreassen
Trygve Christophersen
General Manager:
Mark Walter Meier
Subsidiary companies:
Largest shareholders:
N/A
KEYWORDS
Animal or vegetable oils, Animal or vegetable oils and fats, Basic organic chemicals, Biotechnology, blood-forming organs and the cardiovascular system, chemical products and man-made fibres, Chemicals, Crude animal or vegetable oils and fats, Food products and beverages, Health Care, Medicinal products, Medicinal products for the alimentary tract and metabolism, Medicinal products for the blood, Vegetable oils,